Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05521113 · ClinicalTrials.gov registry record
Home-based Pulmonary Rehabilitation With Remote Monitoring in Pulmonary Arterial Hypertension
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 14
- Enrollment target
NCT05521113: Completed study, sponsored by Mayo Clinic.
NCT05521113 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05521113 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to test new technology and health coaching aimed to help people with PAH become more physically active in their daily lives.
Primary Outcome
Number of adverse events attributed to home-based pulmonary rehabilitation
Interventions
- BEHAVIORAL Home Rehabilitation Monitoring System
- BEHAVIORAL Health coaching calls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2023-06-30 |
What the finished NCT05521113 record still lists
NCT05521113 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Home Rehabilitation Monitoring System is the first listed.
NCT05521113 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05521113 about?
NCT05521113 is a clinical study titled "Home-based Pulmonary Rehabilitation With Remote Monitoring in Pulmonary Arterial Hypertension". The purpose of this study is to test new technology and health coaching aimed to help people with PAH become more physically active in their daily lives.
What is the current status of trial NCT05521113?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2022-09-06. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05521113?
The interventions under investigation include: Home Rehabilitation Monitoring System (BEHAVIORAL), Health coaching calls (BEHAVIORAL).
Who is sponsoring clinical trial NCT05521113?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy